ABO-incompatible liver transplantation for treating primary hepatic neuroendocrine tumor: a case report
10.3760/cma.j.cn421203-20240330-00075
- VernacularTitle:ABO血型不相容肝移植治疗原发性肝脏神经内分泌肿瘤1例
- Author:
Anhua DONG
1
;
Yanfen DAI
;
Yandong SUN
;
Hui ZHANG
;
Jinzhen CAI
Author Information
1. 青岛大学附属医院器官移植中心，青岛 266003
- Publication Type:Journal Article
- Keywords:
Liver transplantation;
ABO-incompatible donated liver;
Primary hepatic neuroendocrine tumor;
Double filtration plasmapheresis
- From:
Chinese Journal of Organ Transplantation
2025;46(3):232-234
- CountryChina
- Language:Chinese
-
Abstract:
Primary hepatic neuroendocrine tumor (PHNET) is an extremely rare subtype of neuroendocrine tumor (NET), accounting for approximately 0.3% - 4.0% of all NETs. This study reports a case of PHNET treated with ABO-incompatible liver transplantation. Intraoperatively, double filtration plasmapheresis was performed to remove antibodies. Postoperatively, the patient's blood concentrations of immunosuppressive drugs and liver function were closely monitored. The recipient maintained stable drug levels, with a gradual recovery of liver function. No acute rejection occurred, and the patient was successfully discharged.
